SCHEMBL2357005

SCHEMBL2357005

CC=CC=CC=CCC(=O)CCC

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.38
CNR2 P34972 9/20 0.34
CNR1 P21554 7/20 0.34
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
TRPA1 O75762 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
FASN P49327 1/20 0.32
FFAR3 O14843 3/20 0.32
HDAC3 O15379 3/20 0.32
HDAC1 Q13547 3/20 0.32
HDAC2 Q92769 3/20 0.32
HDAC8 Q9BY41 3/20 0.32
ALDH1A1 P00352 1/20 0.32
PPARG P37231 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5794471 1.00 SOAT1 (0.38) SOAT1CNR2CNR1CES2CES1
Hydrochloric Acid SCHEMBL28843054 0.98 SOAT1 (0.37) SOAT1CNR2CNR1CES2CES1
SCHEMBL11533285 0.84
SCHEMBL11533281 0.84
SCHEMBL28002547 0.82 SOAT1 (0.40) SOAT1CNR2CNR1TRPA1TRPV1
SCHEMBL2833573 0.82 CES2 (0.32) CES2CES1FASNFFAR3HDAC3
SCHEMBL3080818 0.82 CES2 (0.32) CES2CES1FASNFFAR3HDAC3
SCHEMBL2833574 0.82 CES2 (0.32) CES2CES1FASNFFAR3HDAC3
SCHEMBL17940485 0.82 CES2 (0.32) CES2CES1FASNFFAR3HDAC3
SCHEMBL13021369 0.82 CES2 (0.32) CES2CES1FASNFFAR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118324762-A Compounds and compositions for treating CNS disorders 布鲁奥科制药有限公司 2024-07-12 CN disclosed
EP-4084797-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS Blue Oak Pharmaceuticals, Inc. (US) 2022-11-09 EP disclosed
CN-114929235-A Compounds and compositions for treating CNS disorders 布鲁奥科制药有限公司 2022-08-19 CN disclosed
EP-2350021-A1 BRIDGED TETRAHYDRONAPHTHALENE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2011-08-03 EP disclosed
WO-2010046855-A1 BRIDGED TETRAHYDRONAPHTHALENE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2010-04-29 WO disclosed
EP-1648872-A2 ARYL FUSED AZAPOLYCYCLIC COMPOUNDS Pfizer Products Inc. (US) 2006-04-26 EP disclosed
WO-2005007630-A2 ARYL FUSED AZAPOLYCYCLIC COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-01-27 WO disclosed